|
|
| p345 |
Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours |
Clelia Miracco, Maria Caterina De Nisi, Felice Arcuri, Elena Cosci, Lorenzo Pacenti, Marzia Toscano, Anna Vittoria Lalinga, Maurizio Biagioli, Pietro Rubegni, Rosella Vatti, Emilia Maellaro, Barbara Del Bello, Daniela Massi, Pietro Luzi, Piero Tosi
|
|
|
|
| p375 |
Clinical significance of class III β-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer |
Naomi Urano, Yoshiyuki Fujiwara, Yuichiro Doki, S. J. Kim, Yasuo Miyoshi, Shinzaburo Noguchi, Hiroshi Miyata, Shuji Takiguchi, Takushi Yasuda, Masahiko Yano, Morito Monden
|
|
|
|
| p383 |
Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: A new approach to identify novel tumor markers |
Yukinori Kurokawa, Kimi Honma, Ichiro Takemasa, Shoji Nakamori, Hiroko Kita-Matsuo, Masaaki Motoori, Hiroaki Nagano, Keizo Dono, Takahiro Ochiya, Morito Monden, Kikuya Kato
|
|
|
|
| p431 |
T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma |
Marco Bueter, Martin Gasser, Nicolai Schramm, Tatiana Lebedeva, Georges Tocco, Christiane Gerstlauer, Martin Grimm, Ekaterina Nichiporuk, Andreas Thalheimer, Arnulf Thiede, Detlef Meyer, Gilles Benichou, Ana Maria Waaga-Gasser
|
|
|
|
| p469 |
GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors |
Yoon Lee, Aikaterini Vassilakos, Ningping Feng, Hongnan Jin, Ming Wang, Keyong Xiong, Jim Wright, Aiping Young
|
|
|
|
| p559 |
Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate |
Jitka Stokrová, Eva Sloncová, Vlasta Sovová, Dana Kucerová, Vojtech Zíla, Jolana Turecková, Martina Vojtechová, Jan Korb, Zdena Tuhácková
|
|
|
|
|
|